Skip to content

Electromedical (OTC QB:EMED)

In this podcast, Mr. Wolfson discusses the current state of Electromedical Technologies, their FDA approved product, alternative therapies and 2021 outlook. Headquartered in Scottsdale Arizona, Electromedical Technologies, Inc. (OTCQB: EMED) is a commercial stage, FDA cleared, bioelectronic medical device manufacturing company initially focused on the treatment of various chronic, acute, intractable, and post-operative pain conditions. Through university collaboration agreements the company is working to develop a comprehensive research program in defining the effects of electro-modulation on the human body by studying the impacts of electrical fields in cell signaling and effects on virus assembly and immune responses with the goal of improving human wellbeing. The company’s current cleared product indications are for chronic acute post traumatic and post-operative, intractable pain relief.. For more information, please visit the Company’s website at

Electromedical Technologies Discusses FDA Approved Product, Benefits of Alternative Therapies & More with CEO Matthew Wolfson

Jane King Headshot

Jane King


Matthew Wolfson